Flow cytometry has revolutionized our understanding of cell biology and immunology by revealing previously unappreciated phenotypic and functional heterogeneity of cell subsets. In contrast, our understanding of viral heterogeneity – and the role it may play in transmission, immune responses, and vaccination – is not nearly as well defined. Recent advancements in flow cytometry allow for nanoparticle analysis using a strong fluorescent signal. Here, we utilized fluorescently labeled viral particles to develop techniques to measure viral heterogeneity and perform functional analysis of viral populations purified by FACS.
We compared a standard flow cytometer and a cytometer designed for sub-micron particles for their ability to detect unlabeled or fluorescently labeled viral particles. In addition to labeling structural proteins, we adapted an MS2 RNA loop system to assess viral genome incorporation. Viral particles containing different fluorescent structural and RNA markers were sorted by FACS and analyzed for their ability to infect CD4+ T cells. Specificity of detection and purity of sorts were confirmed by confocal microscopy and standard bulk biochemical techniques.
Fluorescently labeled – but not unlabeled – single viral particles could be identified and distinguished from exosomes on both cytometers. Viral genome incorporation was successfully monitored by colocalization of the fluorescently labeled structural and MS2-tagged proteins with agreement between flow cytometry and microscopy techniques. Viral particles could be sorted by genome incorporation and retained the ability to infect target cells.
Starting with fluorescently labeled viruses, we have developed a ‘toolkit’ to explore the composition and infectivity of individual live viral particles with unprecedented detail. We are currently extending this technique to unlabeled HIV using fluorescently labeled neutralizing and non-neutralizing antibodies against Env proteins. We anticipate that viral heterogeneity will reveal critical insights into viral transmission and vaccine design.